Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Lipska

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Acta Poloniae Pharmaceutica|June 10, 2000
TLC fractionation and visualization of selected phenolic compounds applied as drugsW Wardas, I Lipska, K Bober
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Do HTA Processes Correlate With Reimbursement Recommendations?N Allen, I Lipska, L Liberti, et al.
Clinical Pharmacology and Therapeutics|August 8, 2015
Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions?I Lipska, J Hoekman, N McAuslane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countriesS Kleijnen, I Lipska, T Leonardo Alves, et al.
Health Systems in Transition|May 4, 2012
Poland health system reviewAnna Sagan, Dimitra Panteli, W Borkowski, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Acta Poloniae Pharmaceutica|June 10, 2000
TLC fractionation and visualization of selected phenolic compounds applied as drugsW Wardas, I Lipska, K Bober
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Do HTA Processes Correlate With Reimbursement Recommendations?N Allen, I Lipska, L Liberti, et al.
Clinical Pharmacology and Therapeutics|August 8, 2015
Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions?I Lipska, J Hoekman, N McAuslane, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2016
Relative effectiveness assessments of oncology medicines for pricing and reimbursement decisions in European countriesS Kleijnen, I Lipska, T Leonardo Alves, et al.
Health Systems in Transition|May 4, 2012
Poland health system reviewAnna Sagan, Dimitra Panteli, W Borkowski, et al.
Pageof 1